| Literature DB >> 31850258 |
Gozde Serindere1, Behiye Bolgul2, Didar Gursoy3, Sibel Hakverdi3, Nazan Savas4.
Abstract
BACKGROUND: Although oral health improves in several countries, global problems are still present. Predictably, the disadvantaged and poor population groups in both developing and developed countries have high rate of malign disease. The aim of this study was to evaluate the prevalence of head and neck cancers (HNCs) and to compare them between Syrian and Turkish population.Entities:
Keywords: Cancer; Epidemiology; Head and neck; Pathology
Year: 2019 PMID: 31850258 PMCID: PMC6908918
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Fig. 1a, b:Distribution of the incidence of cancer in the head and neck region
Dispersion of HNCs cancer according to the population
| Turkish | 374 ( 9.1) | 3744 (90.9) | 4118 (100) |
| Syrian | 100 (22.1) | 352 (77.9) | 452 (100) |
| Total | 474 (10.4) | 4096 (89.6) | 4570 (100) |
Fig. 2:Distribution of head and neck cancer according to the location
Dispersion of the incidence of cancer in the head and neck according to the gender and site
| Oral-nose-nasal cavity | 25 | 8 | 22 | 11 | 547 | 0.7 |
| Larynx | 157 | 11 | 128 | 40 | 406 | 3.7 |
| Nasopharynx-Tonsil | 42 | 41 | 68 | 15 | 1391 | 1.8 |
| Tongue | 18 | 8 | 18 | 8 | 197 | 0.6 |
| Lip | 34 | 10 | 33 | 11 | 281 | 1.0 |
| Salivary glands | 13 | 13 | 22 | 4 | 329 | 0.6 |
| Thyroid | 28 | 66 | 83 | 11 | 945 | 2.1 |
| Total | 317 | 157 | 374 | 100 | 4096 | - |
Dispersion of HNCs according to the region in Syrian patients. Percentages are shown in parenthesis. Totals may not equal 100 because of indicating most and least common cancers. Sq. Cell Ca, squamous cell carcinoma, Bas. Cell Ca, Basaloid cell carcinoma, Adeno Ca, Adenocarcinoma
| Oral-nose-nasal cavity | Sq. Cell Ca. (27.2) Bas. Cell Ca. (18.1) | Non-Hodgkin Lymphoma (9.09) |
| Larynx | Sq. Cell Ca. (100) | - |
| Nasopharynx-Tonsil | Sq. Cell Ca. (40) Nasopharygeal ca (26.6) | Hodgkin (6.6) |
| Tongue | Sq. Cell Ca. (87.5) | Borderline (12.5) |
| Lip | Sq. Cell Ca. (80) | Bas. Cell Ca. (10) |
| Salivary glands | Adeno Ca (50) | Sq. Cell Ca. (25) Basaloid SCC (25) |
| Thyroid | Papillary Ca (90.9) | Medullary Ca (9.1) |
Dispersion of HNCs according to the region in Turkish patients. Percentages are shown in parenthesis. Totals may not equal 100 because of indicating most and least common cancers. Sq. Cell Ca, squamous cell carcinoma, Adenoid cystic, Adenoid cystic carcinoma, Mucoepidermoid, Mucoepidermoid carcinoma
| Oral-nose-nasal cavity | Sq. Cell Ca. (71.4) | Bas. Cell Ca. (4.7) |
| Larynx | Sq. Cell Ca. (100) | - |
| Nasopharynx-Tonsil | Non-Hodgkin (44.1) Sq. Cell Ca. (17.6) Nasopharyngeal Ca (22.1) | Mucoepidermoid (1.47) |
| Tongue | Sq. Cell Ca. (100) | - |
| Lip | Sq. Cell Ca. (93.75) | Bas. Cell Ca. (6.25) |
| Salivary glands | Sq. Cell Ca. (27.2) Mucoepidermoid (18.1) | Malignant melanoma (4.5) |
| Thyroid | Papillaryca (93.9) | Medullary ca (6.1) |